Abstract
Objectives
Human CD34+ stem cells differentiated into type-II pneumocytes in Dulbecco’s modified Eagle medium (DMEM) having hydrocortisone, insulin, fibroblast growth factor (FGF), epidermal growth factor (EGF) and bovine serum albumin (BSA), expressing surfactant proteins-B (SP-B) and C (SP-C), alkaline phosphatase (ALP) and lysozyme.
Results
FACS-enumerated pure CD34+ cells, isolated from human peripheral blood, were cultured in DMEM and showed positive reaction with anti-human CD34 monoclonal antibodies in immunocytochemistry. These cells were cultured in DMEM having hydrocortisone, insulin, FGF, EGF and BSA (HIFEB-D) medium having an air–liquid interface. They differentiated into type-II pneumocytes with expression of SP-B and SP-C genes and disappearance of CD34 expression as assessed using real-time PCR. In reverse transcription-PCR amplicons showed 208 and 907 bp confirming SP-B and SP-C expressions. These cells expressed ALP with an activity of 1.05 ± 0.09 mM ml−1 min−1 and lysozyme that killed E. coli.
Conclusion
The successful differentiation of human CD34+ stem cells into type-II pneumocytes, and transplantation of such cells obtained from the patient’s stem cell could be the futuristic approach to regenerate diseased lung alveoli.
Similar content being viewed by others
References
Beers MF, Kim CY, Dodia C, Fisher AB (1994) Synthesis of type II cell lamellar body lysozyme-15 kD protein (lbl-15) by perfused rat lung. Am J Respir Cell Mol Biol 11:240–248
Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, Whitsett JA (1995) Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci 92:7794–7798
Edelson JD, Shannon JM, Mason RJ (1988) Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am Rev Respir Dis 138:1268–1275
Gobran LI, Rooney SA (2004) Pulmonary surfactant secretion in briefly cultured mouse type II cells. Am J Physiol Lung Cell Mol Physiol 286:L331–L336
Grek CL, Newton DA, Wen X, Spyropoulos DD, Baatz JE (2009) Characterization of alveolar epithelial cells cultured in semipermeable hollow fibers. Exp Lung Res 35:155–174
Grove JE, Bruscia E, Krause DS (2004) Plasticity of bone marrow-derived stem cells. Stem Cells 22:487–500
Kunkelmann H, Kleinbauer D, Klink F, Oberheuser F (1988) Effects of intralipid and hydrocortisone upon human fetal lung cell cultures. Res Exp Med 188:411–423
Li X, Yang Q, Bai J, Xuan Y, Wang Y (2015) Identification of appropriate reference genes for human mesenchymal stem cell analysis by quantitative real-time PCR. Biotechnol Lett 37:67–73
Mallampalli RK, Salome RG, Hunninghake GW (1994) Epidermal growth factor is a positive in vivo regulator of CTP: cholinephosphate cytidylyltransferase. Exp Lung Res 20:1–11
Otto WR (1997) Lung stem cells. Int J Exp Pathol 78:291–310
Rippon HJ, Ali NN, Polak JM, Bishop AE (2004) Initial observations on the effect of medium composition on the differentiation of murine embryonic stem cells to alveolar type II cells. Cloning Stem Cells 6:49–56
Sarma PV, Subramanyam G (2008) In vitro cardiogenesis can be initiated in human CD34+ cells. Indian Heart J 60:95–100
Spicer SS, Frayser R, Virella G, Hall BJ (1977) Immunocytochemical localization of lysozymes in respiratory and other tissues. Lab Investig 36:282–295
Venkatesh K, Srikanth L, Vengamma B, Chandrasekhar C, Prasad BC, Sarma PV (2015) In vitro transdifferentiation of human cultured CD34+ stem cells into oligodendrocyte precursors using thyroid hormones. Neurosci Lett 588:36–41
Acknowledgments
We sincerely acknowledge Sri Venkateswara Institute of Medical Sciences (SVIMS University), India for providing funds to carry out the work. This paper forms a part of Ph.D. thesis work going to be submitted to SVIMS University, Tirupati, Andhra Pradesh, India.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Srikanth, L., Venkatesh, K., Sunitha, M.M. et al. In vitro generation of type-II pneumocytes can be initiated in human CD34+ stem cells. Biotechnol Lett 38, 237–242 (2016). https://doi.org/10.1007/s10529-015-1974-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-015-1974-2